Oxford-AstraZeneca COVID-19 vaccine
The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, is a COVID-19 vaccine developed by Oxford University and AstraZeneca given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1.... Wikipedia
- Trade names: COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, Covishield
- data: EU EMA: yes
- Pregnancy, category: AU: B2
- Routes of, administration: Intramuscular
- Legal status: AU: S4, CA: Schedule D, Authorized by interim order, UK: Conditional and temporary authorisation to supply, EU: Conditional marketing authorisation, KR – Approved, IND, INA, BD, AG, SV, DOM, MEX, NE, BR, SL, SRB: Emergency Authorization only
- CAS Number: 2420395-83-9
- ATC code: None
- DrugBank: DB15656
- UNII: B5S3K2V0G8
- Synonyms: AZD1222, ChAdOx1 nCoV-19, ChAdOx1-S
- Data source: DuckDuckGo